Search

Your search keyword '"Bakhtiar, Shahrzad"' showing total 242 results

Search Constraints

Start Over You searched for: Author "Bakhtiar, Shahrzad" Remove constraint Author: "Bakhtiar, Shahrzad"
242 results on '"Bakhtiar, Shahrzad"'

Search Results

1. The GAIN Registry — a New Prospective Study for Patients with Multi-organ Autoimmunity and Autoinflammation

2. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation

3. Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study

4. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

5. Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)

6. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

7. CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany

10. Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study

11. Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III

12. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

14. Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score

15. Survival in primary hemophagocytic lymphohistiocytosis 2016-2021: etoposide is better than its reputation

16. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

17. Incidence of SCID in Germany from 2014 to 2015 an ESPED* Survey on Behalf of the API*** Erhebungseinheit für Seltene Pädiatrische Erkrankungen in Deutschland (German Paediatric Surveillance Unit) ** Arbeitsgemeinschaft Pädiatrische Immunologie

18. Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

21. Rubella Virus-Associated Cutaneous Granulomatous Disease: a Unique Complication in Immune-Deficient Patients, Not Limited to DNA Repair Disorders

22. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

24. Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)

25. Donor‐type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors

27. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency

28. Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

29. Treatment of inborn errors of immunity patients with inflammatory bowel disease phenotype by allogeneic stem cell transplantation

30. Regulatory B cells in patients suffering from inborn errors of immunity with severe immune dysregulation

31. Impaired IL-23–dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency

32. Impaired IL-23-dependent induction of IFN-gamma underlies mycobacterial disease in patients with inherited TYK2 deficiency

33. Therapeutic options for CTLA-4 insufficiency

34. Therapeutic options for CTLA-4 insufficiency

35. Curation and expansion of Human Phenotype Ontology for defined groups of inborn errors of immunity

36. Understanding the role of LFA-1 in leukocyte adhesion deficiency Type I (LAD I): moving towards inflammation?

37. Treatment of inborn errors of immunity patients with inflammatory bowel disease phenotype by allogeneic stem cell transplantation.

38. Treatment of severe forms of LPS-responsive beige-like anchor protein deficiency with allogeneic hematopoietic stem cell transplantation

41. Therapeutic options for CTLA-4 insufficiency

42. Curation and expansion of Human Phenotype Ontology for defined groups of inborn errors of immunity

43. The incidence and type of cancer in patients with ataxia-telangiectasia via a retrospective single-centre study

44. The incidence and type of cancer in patients with ataxia‐telangiectasia via a retrospective single‐centre study

45. Case Report: Symptomatic Chronic Granulomatous Disease in the Newborn

46. Supportive Care During Pediatric Hematopoietic Stem Cell Transplantation: Prevention of Infections. A Report From Workshops on Supportive Care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

47. Supportive care during pediatric hematopoietic stem cell transplantation: prevention of infections. A report from workshops on supportive care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

48. Simple measurement of IgA predicts immunity and mortality in Ataxia-Telangiectasia

49. Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III

50. Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Catalog

Books, media, physical & digital resources